At OBN’s Digital Event series, Domainex experts address how major global events such as the ongoing pandemic are impacting the research focus of R&D companies.

Watch the talk to hear insights into the roles of discovery CROs such as Domainex; our integrated drug discovery platform, including details of our medicinal chemistry drug discovery approach along with case study examples; and predictions for the future of the drug development sector. Plus, hear LUNAC Therapeutics Founder Director, Professor Helen Philippou discuss the journey from academia to a start-up.

Watch now